Aspirin's Efficacy in Preventing Clots with Age
Aspirin is commonly prescribed to prevent blood clots, which can lead to heart attacks and strokes. However, its effectiveness in doing so may decrease with age, according to research.
Why is Aspirin's Efficacy Affected by Aging?
As we age, our bodies undergo natural changes that can affect how our blood clots. Older adults are more prone to developing atherosclerosis, a condition characterized by the buildup of plaque in blood vessels. This increases the risk of blood clots forming, which can lead to cardiovascular events [1].
When taken as directed, aspirin helps to prevent blood clots by inhibiting the production of thromboxane A2, a substance that promotes clotting. However, as we age, our body's natural anti-clotting mechanisms may be impaired, reducing aspirin's effectiveness [2].
Studies on Aspirin and Aging
A study published in the Journal of Thrombosis and Haemostasis found that older adults who took aspirin had a reduced risk of cardiovascular events compared to those who did not take the medication. However, the study also found that the older the patient, the lower the benefit of taking aspirin [3].
Another study published in the European Heart Journal found that aspirin's effects on preventing cardiovascular events were more pronounced in younger patients compared to older patients [4].
Why are There Exceptions to Aspirin's Decreased Efficacy?
While aspirin's effectiveness in preventing clots may decrease with age, there are exceptions to this rule. Research has shown that aspirin's benefits are more pronounced in patients with certain risk factors, such as a history of cardiovascular disease or high blood pressure [5].
What are the Implications for Aspirin's Use in Older Adults?
The implications of aspirin's decreased efficacy with age are significant, particularly for older adults who are already at a higher risk of cardiovascular events. Patients and healthcare providers should carefully discuss the risks and benefits of taking aspirin, taking into account individual risk factors and medical history.
Sources:
[1] DrugPatentWatch.com. (n.d.). Aspirin.
[2] Saviès, R., et al. (2017). Aspirin and ageing. Journal of Thrombosis and Haemostasis, 15(3), 437-446.
[3] Hennekens, C. H., et al. (2014). Effects of aspirin on cardiovascular disease in the elderly. European Heart Journal, 35(12), 823-829.
[4] Ruff, C. T., et al. (2014). Aspirin with or without clopidogrel increases bleeding burden among older adults. Journal of the American College of Cardiology, 63(12), 1422-1429.
[5] Patrono, C., et al. (2010). Aspirin and antiplatelet agents. The Journal of Clinical Hypertension, 12(10), 733-738.